Metabolic network as a progression biomarker of premanifest Huntington’s disease

Background. The evaluation of effective disease-modifying therapies for neurodegenerative disorders relies on objective and accurate measures of progression in at-risk individuals. Here we used a computational approach to identify a functional brain network associated with the progression of preclin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Tang, Chris C., Feigin, Andrew, Ma, Yilong, Habeck, Christian, Paulsen, Jane S., Leenders, Klaus L., Teune, Laura K., van Oostrom, Joost C.H., Guttman, Mark, Dhawan, Vijay, Eidelberg, David
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Clinical Investigation 2013
Onderwerpen:
Clinical Medicine
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754266/
https://ncbi.nlm.nih.gov/pubmed/23985564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69411
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items